Back to Report Store Home

Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues

  • Published: May-2011
  • Report Code: GBIHC089MR
  • Report Format: pdf

Description

List of Tables

Table 1: Generic Growth Strategies , Notable Patent Expiries Due by 2014 11

Table 2: Generic Growth Strategies, Market Rules for Use of Generic Drugs Across Certain EU Markets 18

Table 3: Generic Growth Strategies, Market Incentives for Use of Generic Drugs Across Certain EU Markets 18

Table 4: Generic Growth Strategies, Notable Authorized Generics by 2010 32

Table 5: Generic Growth Strategies, Strengthening Backward Integration 34

Table 6: Generic Growth Strategies, Biosimilars Approval Pathways in the US and Europe, Patent Expiry for Major Biologic Drugs, 2010-2016 51

Table 7: Generic Growth Strategies, Top Generics Manufacturers by Sales, 2004 and 2009 53

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards